^"Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
^"Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
^Gaugler B, Brouwenstijn N, Vantomme V, Szikora JP, Van der Spek CW, Patard JJ, Boon T, Schrier P, Van den Eynde BJ (Oct 1996). "A new gene coding for an antigen recognized by autologous cytolytic T lymphocytes on a human renal carcinoma". Immunogenetics. 44 (5): 323–30. doi:10.1007/BF02602776. PMID8781117. S2CID20056364.
Eichmüller S, Usener D, Jochim A, Schadendorf D (August 2002). "mRNA expression of tumor-associated antigens in melanoma tissues and cell lines". Experimental Dermatology. 11 (4): 292–301. doi:10.1034/j.1600-0625.2002.110402.x. PMID12190937. S2CID22559064.
Götte K, Usener D, Riedel F, Hörmann K, Schadendorf D, Eichmüller S (July 2002). "Tumor-associated antigens as possible targets for immune therapy in head and neck cancer: comparative mRNA expression analysis of RAGE and GAGE genes". Acta Oto-Laryngologica. 122 (5): 546–52. doi:10.1080/00016480260092381. PMID12206267. S2CID7087339.
Yan M, Ghorab Z, Nadji M (June 2003). "Renal cell carcinoma antigen is expressed by yolk sac tumors and yolk sac elements of embryonal carcinomas". Applied Immunohistochemistry & Molecular Morphology. 11 (2): 113–5. doi:10.1097/00129039-200306000-00003. PMID12777992. S2CID29045611.
Miura J, Uchigata Y, Yamamoto Y, Takeuchi M, Sakurai S, Watanabe T, Yonekura H, Yamagishi S, Makita Z, Sato A, Omori Y, Yamamoto H, Iwamoto Y (2004). "AGE down-regulation of monocyte RAGE expression and its association with diabetic complications in type 1 diabetes". Journal of Diabetes and Its Complications. 18 (1): 53–9. doi:10.1016/S1056-8727(02)00281-7. PMID15019601.
Rudofsky G, Isermann B, Schilling T, Schiekofer S, Andrassy M, Schneider JG, Morcos M, Humpert PM, Sayed AA, Witte S, Renn W, Pfohl M, Hamann A, Nosikov V, Schleicher E, Häring HU, Rudofsky G, Ritz E, Nawroth PP, Bierhaus A (March 2004). "A 63bp deletion in the promoter of rage correlates with a decreased risk for nephropathy in patients with type 2 diabetes". Experimental and Clinical Endocrinology & Diabetes. 112 (3): 135–41. doi:10.1055/s-2004-817822. PMID15052533. S2CID260134909.
Uesaka T, Kageyama N (August 2004). "Cdx2 homeodomain protein regulates the expression of MOK, a member of the mitogen-activated protein kinase superfamily, in the intestinal epithelial cells". FEBS Letters. 573 (1–3): 147–54. doi:10.1016/j.febslet.2004.07.070. PMID15327990. S2CID42372904.
Grunau C, Sanchez C, Ehrlich M, van der Bruggen P, Hindermann W, Rodriguez C, Krieger S, Dubeau L, Fiala E, De Sario A (May 2005). "Frequent DNA hypomethylation of human juxtacentromeric BAGE loci in cancer". Genes, Chromosomes & Cancer. 43 (1): 11–24. doi:10.1002/gcc.20155. PMID15704127. S2CID38956616.
dos Santos KG, Canani LH, Gross JL, Tschiedel B, Pires Souto KE, Roisenberg I (June 2005). "The -374A allele of the receptor for advanced glycation end products gene is associated with a decreased risk of ischemic heart disease in African-Brazilians with type 2 diabetes". Molecular Genetics and Metabolism. 85 (2): 149–56. doi:10.1016/j.ymgme.2005.02.010. PMID15896660.
Haslbeck KM, Friess U, Schleicher ED, Bierhaus A, Nawroth PP, Kirchner A, Pauli E, Neundörfer B, Heuss D (September 2005). "The RAGE pathway in inflammatory myopathies and limb girdle muscular dystrophy". Acta Neuropathologica. 110 (3): 247–54. doi:10.1007/s00401-005-1043-3. PMID15986224. S2CID19040474.
Dumitriu IE, Bianchi ME, Bacci M, Manfredi AA, Rovere-Querini P (January 2007). "The secretion of HMGB1 is required for the migration of maturing dendritic cells". Journal of Leukocyte Biology. 81 (1): 84–91. doi:10.1189/jlb.0306171. PMID17035340. S2CID43269992.